Generics 1



Medical devices



Clindamycin manufacturers

1 products found



Filters , active

Country of origin : Philippines

Clear all

1 products found


Capsules 150 mg

Dossier type
Dossier status
Ready to file
Country of origin
GMP approvals
Manufacturer #21232

Clindamycin Manufactureres

Clindamycin is an antibiotic that is used to treat bacterial infections such as bone, joint, and pelvic inflammatory disease, as well as various infections of the ear, nose, and throat, and endocarditis. Acne, tooth infections, skin and soft tissue infections, and peritonitis can all be treated with it. Clindamycin is used to treat infections caused by susceptible aerobic bacteria in patients who are allergic to penicillins. Clindamycin phosphate is also used to treat mild to moderate acne and some cases of methicillin-resistant Staphylococcus aureus when applied topically. Clindacin, Cleocin HCl, Evoclin,Dalacin, and Lincocin are all brands of clindamycin. Clindamycin was initially isolated from lincomycin, a naturally occurring antibiotic discovered in an Alaskan plant, in 1966. It's a generic medicine that's on the World Health Organization's Essential Medicines List. Clindamycin has a bacteriostatic action, which means it slows or stops germs from multiplying. Clindamycin, like antibiotics, acts by blocking bacterial protein synthesis and thereby preventing bacterial growth. It also has a bacteriostatic effect, which means it prevents germs from multiplying but does not kill them.Clindamycin inhibits early chain elongation by attaching to the 50s ribosomal subunit of bacteria and affecting protein synthesis in the process by interfering with the transpeptidation step. Nausea, diarrhea, redness, and soreness at the injection site are all common side effects of Clindamycin use. Topical clindamycin and benzoyl peroxide combination for long-term acne therapy perform similarly to salicylic acid plus benzoyl peroxide.

Price of Clindamycin

The wholesale cost in the poor world is US$0.06 to US$0.12 for each tablet, whereas the same medicine costs roughly $2.70 per dose in the United States, with an average price of $95.99 for 30 Capsules of 300mg each of the generic brands.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection ofClindamycin offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Clindamycin manufacturers and Clindamycin suppliers that you are looking for. These also enable you to check the dossier status of Clindamycin, and the GMP approvals of the different variants of Clindamycin. Also, each manufacturer or supplier product description contains essential information about Clindamycin including clinical data, stability zones, countries where Clindamycin is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Clindamycin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Clindamycin manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Clindamycin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.